Guggenheim Capital LLC Amicus Therapeutics, Inc. Transaction History

Guggenheim Capital LLC

$12 Billion
Q4 2024

A detailed history of Guggenheim Capital LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 81,767 shares of FOLD stock, worth $751,438. This represents 0.01% of its overall portfolio holdings.

Number of Shares

81,767

Previous 94,977 13.91%

Holding current value

$751,438

Previous $1.01 Million 24.06%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$9.36 - $12.01 $123,645 - $158,652	-13,210 Reduced 13.91%	81,767 $770,000
Q3 2024 Nov 13, 2024	SELL	$9.55 - $12.09 $10,867 - $13,758	-1,138 Reduced 1.18%	94,977 $1.01 Million
Q2 2024 Aug 14, 2024	SELL	$9.04 - $11.75 $20,701 - $26,907	-2,290 Reduced 2.33%	96,115 $953,000
Q1 2024 May 14, 2024	BUY	$11.43 - $14.24 $34,781 - $43,332	3,043 Added 3.19%	98,405 $1.16 Million
Q4 2023 Feb 14, 2024	SELL	$9.97 - $14.52 $52,252 - $76,099	-5,241 Reduced 5.21%	95,362 $1.35 Million
Q3 2023 Nov 14, 2023	SELL	$11.78 - $13.86 $29,685 - $34,927	-2,520 Reduced 2.44%	100,603 $1.22 Million
Q2 2023 Aug 11, 2023	SELL	$10.72 - $13.3 $31,849 - $39,514	-2,971 Reduced 2.8%	103,123 $1.3 Million
Q1 2023 May 10, 2023	BUY	$10.91 - $13.54 $1.16 Million - $1.44 Million	106,094 New	106,094 $1.18 Million
Q2 2022 Aug 15, 2022	SELL	$6.23 - $11.12 $47,030 - $83,944	-7,549 Reduced 18.99%	32,199 $346,000
Q1 2022 May 16, 2022	BUY	$7.89 - $12.48 $23,614 - $37,352	2,993 Added 8.14%	39,748 $377,000
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $1.29 Million - $1.63 Million	-130,987 Reduced 78.09%	36,755 $425,000
Q3 2021 Nov 15, 2021	SELL	$8.74 - $11.84 $123,959 - $167,926	-14,183 Reduced 7.8%	167,742 $1.6 Million
Q2 2021 Aug 13, 2021	SELL	$8.71 - $10.72 $40,370 - $49,687	-4,635 Reduced 2.48%	181,925 $1.75 Million
Q1 2021 May 13, 2021	BUY	$9.2 - $23.86 $421,930 - $1.09 Million	45,862 Added 32.6%	186,560 $1.84 Million
Q4 2020 Feb 16, 2021	BUY	$13.47 - $24.89 $1.6 Million - $2.97 Million	119,126 Added 552.23%	140,698 $3.25 Million
Q3 2020 Nov 13, 2020	BUY	$12.89 - $15.89 $278,063 - $342,779	21,572 New	21,572 $305,000
Q2 2019 Aug 14, 2019	SELL	$10.96 - $14.4 $578,435 - $759,988	-52,777 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$10.04 - $13.92 $17,841 - $24,735	-1,777 Reduced 3.26%	52,777 $718,000
Q4 2018 Feb 14, 2019	SELL	$8.38 - $13.44 $1.87 Million - $3.01 Million	-223,720 Reduced 80.4%	54,554 $522,000
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $206,665 - $294,676	17,816 Added 6.84%	278,274 $3.36 Million
Q2 2018 Aug 14, 2018	BUY	$13.13 - $17.09 $434,668 - $565,764	33,105 Added 14.56%	260,458 $4.07 Million
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $240,387 - $299,086	17,470 Added 8.32%	227,353 $3.42 Million
Q4 2017 Feb 14, 2018	SELL	$12.51 - $16.24 $750,912 - $974,805	-60,025 Reduced 22.24%	209,883 $3.02 Million
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $3.17 Million - $4.26 Million	269,908	269,908 $4.07 Million

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

311M

Call Options Held

467K

Put Options Held

515K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.58B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Amicus Therapeutics, Inc. Transaction History